Direct Pulp Capping Clinical Trial
Official title:
Clinical and Radiographic Assessment of Platelet Rich Fibrin and Mineral Trioxide Aggregate as Pulp Capping Biomaterials: A Randomized Control Trial
eligible carious teeth with exposed pulp by the undergraduate students will be randomly divided into two groups to be treated with direct pulp capping (A), where (A1) represents the comparator group where teeth will be treated with direct application of MTA over the exposed pulp, (A2) represents teeth to be treated with the application of PRF directly over exposed pulp followed by MTA application. clinical and radiographic assessment of tooth vitality, history of pain, pain on percussion, and dentin bridge formation will be performed at baseline, 6 months, and 1 year
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05167123 -
Pulp Capping in Primary Molars Using TheraCal (LC)
|
Phase 4 | |
Terminated |
NCT01066533 -
Immunohistochemical Study of Human Teeth Pulp Capped With Mineral Trioxide Aggregate (MTA) and Novel Endodontic Cement (NEC)
|
Phase 4 | |
Active, not recruiting |
NCT05496257 -
Calcium Hydroxide Versus Premixed Bioceramic Putty in Direct Pulp Capping of Primary Molars
|
N/A | |
Completed |
NCT05530954 -
Direct Pulp Capping in Primary Molars
|
Phase 3 | |
Completed |
NCT05297344 -
Clinical Study of the Direct Pulp Capping in Primary Teeth
|
N/A |